| [1］Sattar N，Preiss D，Murray HM，et al.Statins and risk of incident diabetes：a collaborative meta-analysis of randomised statin trials［J］.Lancet，2010，375(9716)：735-742. [2］Navarese EP，Buffon A，Andreotti F，et al.Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus［J］.Am J Cardiol，2013，111(8)：1123-1130. [3］Yada T，Nakata M，Shiraishi T，et al.Inhibition by simvastatin，but not pravastatin，of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells［J］.Br J Pharmacol，1999，126(5)：1205-1213. [4］Xia F，Xie L，Mihic A，et al.Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells［J］.Endocrinology，2008，149(10)：5136-5145. [5］Nakata M，Nagasaka S，Kusaka I，et al.Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4)：implications in glycaemic control［J］.Diabetologia，2006，49(8)：1881-1892. [6］Takaguri A，Satoh K，Itagaki M，et al.Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes［J］.J Pharmacol Sci，2008，107(1)：80-89. [7］Goto T，Nagai H，Egawa K，et al.Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARgamma agonist［J］.Biochem J，2011，438(1)：111-119. [8］Ganesan S，Ito MK.Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3 T3-L1 adipocytes［J］.Metab Syndr Relat Disord，2013，11(4)：251-255. [9］Le Lay S，Krief S，Farnier C，et al.Cholesterol，a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes［J］.J Biol Chem，2001，276(20)：16904-16910. [10］Maeda N，Shimomura I，Kishida K，et al.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.Nat Med 2002，8(7)：731-737. [11］Wanders D，Plaisance EP，Judd RL.Lipid-lowering drugs and circulating adiponectin［J］.Vitam Horm,2012，90：341-374. [12］Chetboun M，Abitbol G，Rozenberg K，et al.Maintenance of redox state and pancreatic beta-cell function：role of leptin and adiponectin［J］.J Cell Biochem，2012，113(6)：1966-1976. [13］Sun YM，Li J，Luan Y，et al.Effect of statin therapy on leptin levels in patients with coronary heart disease［J］.Peptides，2010，31(6)：1205-1207. [14］Bellia A，Rizza S，Lombardo MF，et al.Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy［J］.Atherosclerosis，2012，223(1)：197-203. [15］Larsen S，Stride N，Hey-Mogensen M，et al.Simvastatin effects on skeletal muscle：relation to decreased mitochondrial function and glucose intolerance［J］.J Am Coll Cardiol，2013，61(1)：44-53. [16］Wijesekara N，Zhang LH，Kang MH，et al.miR-33a modulates ABCA1 expression，cholesterol accumulation，and insulin secretion in pancreatic islets［J］.Diabetes，2012，61(3)：653-658. [17］Allen RM，Marquart TJ，Albert CJ，et al.miR-33 controls the expression of biliary transporters，and mediates statin- and diet-induced hepatotoxicity［J］.EMBO Mol Med，2012，4(9)：882-895. [18］Preiss D，Seshasai S，Welsh P，et al.Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy：a meta-analysis［J］.JAMA，2011，305(24)：2556-2564. [19］Waters DD，Ho JE，DeMicco DA，et al.Predictors of new-onset diabetes in patients treated with atorvastatin：results from 3 large randomized clinical trials［J］.J Am Coll Cardiol，2011，57(14)：1535-1545. [20］Axsom K，Berger JS，Schwartzbard AZ.Statins and diabetes：the good，the bad，and the unknown［J］.Curr Atheroscler Rep，2013，15(2)：299. |
